161 related articles for article (PubMed ID: 37847361)
1. ITGB4 Serves as an Identification and Prognosis Marker Associated with Immune Infiltration in Small Cell Lung Carcinoma.
Li GS; Huang ZG; He RQ; Zhang W; Tang YX; Liu ZS; Gan XY; Tang D; Li DM; Tang YL; Zhan YT; Dang YW; Zhou HF; Zheng JH; Jin MH; Tian J; Chen G
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37847361
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers.
Li GS; Chen G; Liu J; Tang D; Zheng JH; Luo J; Jin MH; Lu HS; Bao CX; Tian J; Deng WS; Fu JW; Feng Y; Zeng NY; Zhou HF; Kong JL
BMC Pulm Med; 2022 Jun; 22(1):246. PubMed ID: 35751045
[TBL] [Abstract][Full Text] [Related]
3. CDK6 is a novel predictive and prognosis biomarker correlated with immune infiltrates in multiple human neoplasms, including small cell lung carcinoma.
Li GS; Huang ZG; Li DM; Tang YL; Zheng JH; Yang L; Feng Y; Peng JX; Li JX; Tang YX; Zeng NY; Jin MH; Tian J; Liu J; Zhou HF; Chen G; Chen F
Funct Integr Genomics; 2023 Nov; 23(4):332. PubMed ID: 37950078
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer.
Tang YL; Li GS; Li DM; Tang D; Huang JZ; Feng H; He RQ; Huang ZG; Dang YW; Kong JL; Gan TQ; Zhou HF; Zeng JJ; Chen G
BMC Pulm Med; 2022 Aug; 22(1):300. PubMed ID: 35927660
[TBL] [Abstract][Full Text] [Related]
5. Ogt Demonstrated Conspicuous Clinical Significance in Cancers, from Pan-Cancer to Small-Cell Lung Cancer.
Tang D; Li GS; Xu RX; Zhu SY; Luo J; Zheng JH; Liu J; Lu HS; Jin MH; Bao CX; Tian J; Deng WS; Zeng NY; Zhou HF; Kong JL; Chen G
J Oncol; 2022; 2022():2010341. PubMed ID: 35356257
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive investigation regarding the clinical significance of ITGB4 in oral squamous cell carcinoma combining immunohistochemistry, RNA-seq, and microarray data.
Wang XM; Chen G; Dang YW; Li J; Li P; Li ZY
Comput Biol Chem; 2023 Jun; 104():107846. PubMed ID: 36934520
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance and potential molecular mechanism of integrin subunit beta 4 in laryngeal squamous cell carcinoma.
Zhong F; Lu HP; Chen G; Dang YW; Li GS; Chen XY; Qin YY; Yao YX; Zhang XG; Liang Y; Li MX; Mo M; Zhang KL; Ding H; Huang ZG; Wei ZX
Pathol Res Pract; 2020 Feb; 216(2):152785. PubMed ID: 31889588
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1
Ma SR; Liu JF; Jia R; Deng WW; Jia J
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371594
[TBL] [Abstract][Full Text] [Related]
9. CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers.
Li GS; Zhang W; Huang WY; He RQ; Huang ZG; Gan XY; Yang Z; Dang YW; Kong JL; Zhou HF; Chen G
BMC Pulm Med; 2023 May; 23(1):166. PubMed ID: 37173675
[TBL] [Abstract][Full Text] [Related]
10. SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer.
Hou W; Li GS; Gao L; Lu HP; Zhou HF; Kong JL; Chen G; Xia S; Wei HY
BMC Med Genomics; 2022 May; 15(1):114. PubMed ID: 35581615
[TBL] [Abstract][Full Text] [Related]
11. Identification of Immune Infiltration and Prognostic Biomarkers in Small Cell Lung Cancer Based on Bioinformatic Methods from 3 Studies.
Cao J; Yu C
Comb Chem High Throughput Screen; 2023; 26(3):507-516. PubMed ID: 35400336
[TBL] [Abstract][Full Text] [Related]
12. YTHDF2 negatively correlates with tumor immune infiltration in small cell lung cancer.
Chen G; Ren D; Wang Y; Wang H; Zhang J; Yang S
J Mol Histol; 2023 Aug; 54(4):365-377. PubMed ID: 37357252
[TBL] [Abstract][Full Text] [Related]
13. ITGB4 is a novel prognostic factor in colon cancer.
Li M; Jiang X; Wang G; Zhai C; Liu Y; Li H; Zhang Y; Yu W; Zhao Z
J Cancer; 2019; 10(21):5223-5233. PubMed ID: 31602273
[TBL] [Abstract][Full Text] [Related]
14. Integrin β4 Regulates Cell Migration of Lung Adenocarcinoma Through FAK Signaling.
Zhang S; Liu C; Liu D; Ning X; Li H; Zhang X; Lu Y; Zhang P; Chen S; Cai Z
Mol Biotechnol; 2024 Feb; ():. PubMed ID: 38332433
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a ferroptosis-related prognostic risk-scoring model and key genes in small cell lung cancer.
Li S; Qiu G; Wu J; Ying J; Deng H; Xie X; Lin X; Xie Z; Qin Y; Wang Y; Ma X; Brcic L; Provencio M; Chen Y; Zhou C; Liu M
Transl Lung Cancer Res; 2022 Jul; 11(7):1380-1393. PubMed ID: 35958330
[TBL] [Abstract][Full Text] [Related]
16. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Integrin Subunit Beta 4 in Head and Neck Squamous Cell Carcinoma.
Li GS; Hou W; Chen G; Yao YX; Chen XY; Zhang XG; Liang Y; Li MX; Huang ZG; Dang YW; Liang QH; Wu HY; Li RQ; Wei HY
Cancer Biother Radiopharm; 2022 May; 37(4):256-275. PubMed ID: 33179959
[No Abstract] [Full Text] [Related]
18. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
[TBL] [Abstract][Full Text] [Related]
19. Decrease of interleukin-2 secretion is a new independent prognostic factor associated with poor survival in patients with small-cell lung cancer.
Fischer JR; Schindel M; Bülzebruck H; Lahm H; Krammer PH; Drings P
Ann Oncol; 1997 May; 8(5):457-61. PubMed ID: 9233525
[TBL] [Abstract][Full Text] [Related]
20. A Pan-Cancer Analysis of the Oncogenic Role of Integrin Beta4 (ITGB4) in Human Tumors.
Huang W; Fan L; Tang Y; Chi Y; Li J
Int J Gen Med; 2021; 14():9629-9645. PubMed ID: 34924769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
